Patents Assigned to Axiom Biotechnologies
  • Patent number: 6558916
    Abstract: The present invention is directed to a method for determining the effect of each of a plurality of test agents on cells from a subject, and a method to profile patient cell responses to test agents.
    Type: Grant
    Filed: February 7, 2001
    Date of Patent: May 6, 2003
    Assignee: Axiom Biotechnologies, Inc.
    Inventors: Pandi Veerapandian, Gregory Kaler
  • Patent number: 6379917
    Abstract: An apparatus and method for real-time measurement of a cellular response of a test compound or series of test compounds (303) on a flowing suspension of cells (349), in which a homogenous suspension of each member of a series of cell types (349) is combined with a concentration of a test compound (303), directed through a detection zone (355), and a cellular response of the living cells is measured in real time as the cells in the test mixture are flowing through the detection zone (355). The apparatus may be used in automated screening of libraries of compounds, and is capable of real-time variation of concentrations of test and standard compounds and generation of dose/response profiles within a short timespan.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: April 30, 2002
    Assignee: Axiom Biotechnologies
    Inventors: Ilya Okun, Alex Okun
  • Patent number: 6287758
    Abstract: Sensitive methods for identifying compounds having biological activity comprising combining living cells with two fluorescent membrane permeable ionic dyes having the same charge sign, the first of which has an emission spectrum which overlaps the excitation spectrum of the second fluorescent membrane penetrative dye. The fluorescence is then induced by illuminating the dyes at a wavelength corresponding to the excitation spectrum of the first fluorescent dye and emission is then registered at a wavelength corresponding to the emission spectrum of the second fluorescent dye (FRET). The change in the FRET is indicative of a modulation of cell membrane potential by the biologically active compounds.
    Type: Grant
    Filed: March 23, 2000
    Date of Patent: September 11, 2001
    Assignee: Axiom Biotechnologies, Inc.
    Inventors: Ilya Okun, Alex Okun, Gregory Kaler
  • Patent number: 6280967
    Abstract: An apparatus and method for real-time measurement of a cellular response of a test compound or series of test compounds (303) on a flowing suspension of cells (349), in which a homogeneous suspension of each member of a series of cell types (349) is combined with a concentration of a test compound (303), directed through a detection zone (355), and a cellular response of the living cells is measured in real time as the cells in the test mixture are flowing through the detection zone (355). The apparatus may be used in automated screening of libraries of compounds, and is capable of real-time variation of concentrations of test and standard compounds and generation of dose/response profiles within a short time span.
    Type: Grant
    Filed: August 5, 1999
    Date of Patent: August 28, 2001
    Assignee: Axiom Biotechnologies, Inc.
    Inventors: John Ransom, Ilya Okun, Alex Okun
  • Patent number: 6242209
    Abstract: An apparatus and method for real-time measurement of a cellular response of a test compound or series of test compounds (303) on a flowing suspension of cells (349), in which a homogeneous suspension of each member of a series of cell types (349) is combined with a concentration of a test compound (303), directed through a detection zone (355), and a cellular response of the living cells is measured in real time as the cells in the test mixture are flowing through the detection zone (355). The apparatus may be used in automated screening of libraries of compounds, and is capable of real-time variation of concentrations of test and standard compounds and generation of dose/response profiles within a short time span.
    Type: Grant
    Filed: May 10, 2000
    Date of Patent: June 5, 2001
    Assignee: Axiom Biotechnologies, Inc.
    Inventors: John Ransom, Ilya Okun, Alex Okun
  • Patent number: 6096509
    Abstract: An apparatus and method for real-time measurement of a cellular response of a test compound or series of test compounds (303) on a flowing suspension of cells (349), in which a homogeneous suspension of each member of a series of cell types (349) is combined with a concentration of a test compound (303), directed through a detection zone (355), and a cellular response of the living cells is measured in real time as the cells in the test mixture are flowing through the detection zone (355). The apparatus may be used in automated screening of libraries of compounds, and is capable of real-time variation of concentrations of test and standard compounds and generation of dose/response profiles within a short timespan.
    Type: Grant
    Filed: May 24, 1999
    Date of Patent: August 1, 2000
    Assignee: Axiom Biotechnologies, Inc.
    Inventors: Ilya Okun, Alex Okun
  • Patent number: 5919646
    Abstract: An apparatus and method for real-time measurement of a cellular response of a test compound or series of test compounds (303) on a flowing suspension of cells (349), in which a homogeneous suspension of each member of a series of cell types (349) is combined with a concentration of a test compound (303), directed through a detection zone (355), and a cellular response of the living cells is measured in real time as the cells in the test mixture are flowing through the detection zone (355). The apparatus may be used in automated screening of libraries of compounds, and is capable of real-time variation of concentrations of test and standard compounds and generation of dose/response profiles within a short timespan.
    Type: Grant
    Filed: August 1, 1997
    Date of Patent: July 6, 1999
    Assignee: Axiom Biotechnologies, Inc.
    Inventors: Ilya Okun, Alex Okun
  • Patent number: 5804436
    Abstract: An apparatus and method for real-time measurement of a cellular response of a test compound or series of test compounds on a flowing suspension of cells in which a homogeneous suspension of living cells is combined with a concentration of a test compound, directed through a detection zone, and a cellular response of the living cells is measured in real time as the cells in the test mixture are flowing through the detection zone. The apparatus may be used in automated screening of libraries of compounds, and is capable of real-time variation of concentrations of test and standard compounds and generation of dose/response profiles within a short timespan.
    Type: Grant
    Filed: August 2, 1996
    Date of Patent: September 8, 1998
    Assignee: Axiom Biotechnologies, Inc.
    Inventors: Ilya Okun, Alex Okun